Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 53737-53738 [2018-23230]
Download as PDF
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 206 / Wednesday, October 24, 2018 / Notices
Kenneth A. Bauer II (MI)
Teresia K. Beaty (IN)
Mycah M. Bliesmer (MN)
Theodore F. Brassley, Jr. (ME)
Al C. Broom (CA)
David A. Bruns (IN)
Todd W. Burdick (WI)
William T. Casey (MN)
Anthony Castano (FL)
Richard T. Cisson III (FL)
John F. Daley (RI)
Erik T. Davis (MS)
Robert J. Degrave (VA)
Paul A. Diokpa (IL)
Richard E. Dodge (OR)
Jeramy A. Elley (MT)
John A. Evenson (MN)
Gregory L. Faison (MD)
Ronald N. Falkowski (WI)
Shawn L. Floyd (IL)
Terrence M. Fontaine (MA)
David G. Foster (MI)
Daniel A. Fry (PA)
Samuel L. Gillespie (TN)
Eddie C. Hall (FL)
Jacob E. Heubner (IN)
Michael P. Johnson (MN)
Ryan J. Keys (NY)
James C. Lee, Jr. (GA)
Harold W. Lewis, Jr. (MD)
Edward T. Martin (MN)
Clavenda L. Mason (MD)
Derek A. McGinty (WI)
Pamela J. Meziere (MS)
Mark A. Miller (IN)
Donald R. Mocaby (IL)
David B. Morel (NH)
Cornelius W. Ott, Jr. (IL)
Gene H. Owens (KS)
Jarek D. Perkins (OH)
Austin S. Pihuliak (OH)
Michael P. Poisson (MI)
Carl E. Rhoads (IL)
John W. Ringbloom (PA)
Leslie M. Rinker (VA)
Rocky G. Roof (MO)
Lance U. Sapp (ND)
Dwayne E. Smith (NY)
Brian C. Smith (CA)
Alex L. Soto (CA)
Scott K. Stauffer (PA)
Jerry F. Summers (NH)
Gary R. Waldvogel (MN)
Lee H. Watkins (OH)
John D. Wenger, Jr. (MO)
David B. Whitehead (NC)
John J. Wille III (UT)
Douglas W. Winslow (IL)
Christopher S. Wright (IL)
In accordance with 49 U.S.C. 31136(e)
and 31315, each exemption will be valid
for two years from the effective date
unless revoked earlier by FMCSA. The
exemption will be revoked if the
following occurs: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
VerDate Sep<11>2014
17:43 Oct 23, 2018
Jkt 247001
53737
was maintained prior to being granted;
or (3) continuation of the exemption
would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and
31315.
on the Ground Floor of the DOT West
Building, 1200 New Jersey Avenue SE,
Washington, DC 20590, between 9 a.m.
and 5 p.m., ET., Monday through
Friday, except Federal holidays.
Issued on: October 15, 2018.
Larry W. Minor,
Associate Administrator for Policy.
B. Privacy Act
In accordance with 5 U.S.C. 553(c),
DOT solicits comments from the public
to better inform its rulemaking process.
DOT posts these comments, without
edit, including any personal information
the commenter provides, to
www.regulations.gov, as described in
the system of records notice (DOT/ALL–
14 FDMS), which can be reviewed at
www.dot.gov/privacy.
[FR Doc. 2018–23229 Filed 10–23–18; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2018–0202]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 39 individuals from
the prohibition in the Federal Motor
Carrier Safety Regulations (FMCSRs)
against persons with insulin-treated
diabetes mellitus (ITDM) from operating
a commercial motor vehicle (CMV) in
interstate commerce. The exemptions
enable these individuals with ITDM to
operate CMVs in interstate commerce.
DATES: The exemptions were applicable
on September 15, 2018. The exemptions
expire on September 15, 2020.
FOR FURTHER INFORMATION CONTACT:
Ms. Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001. Office
hours are from 8:30 a.m. to 5 p.m., ET,
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing or submitting
material to the docket, contact Docket
Services, telephone (202) 366–9826.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Public Participation
A. Viewing Documents and Comments
To view comments, as well as any
documents mentioned in this notice as
being available in the docket, go to
https://www.regulations.gov. Insert the
docket number, FMCSA–2018–0202, in
the keyword box, and click ‘‘Search.’’
Next, click the ‘‘Open Docket Folder’’
button and choose the document to
review. If you do not have access to the
internet, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
PO 00000
Frm 00134
Fmt 4703
Sfmt 4703
II. Background
On August 15, 2018, FMCSA
published a notice announcing receipt
of applications from 39 individuals
requesting an exemption from diabetes
requirement in 49 CFR 391.41(b)(3) and
requested comments from the public (83
FR 40642). The public comment period
ended on September 14, 2018, and no
comments were received.
FMCSA has evaluated the eligibility
of these applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
The physical qualification standard
for drivers regarding diabetes found in
49 CFR 391.41(b)(3) states that a person
is physically qualified to drive a CMV
if that person has no established
medical history or clinical diagnosis of
diabetes mellitus currently requiring
insulin for control.
III. Discussion of Comments
FMCSA received no comments in this
proceeding.
IV. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption for up
to five years from the diabetes standard
in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or
greater level of safety than would be
achieved without the exemption. The
exemption allows the applicants to
operate CMVs in interstate commerce.
FMCSA grants exemptions from the
FMCSRs for a two-year period to align
with the maximum duration of a
driver’s medical certification.
The Agency’s decision regarding these
exemption applications is based on the
program eligibility criteria and an
individualized assessment of
information submitted by each
applicant. The qualifications,
E:\FR\FM\24OCN1.SGM
24OCN1
53738
Federal Register / Vol. 83, No. 206 / Wednesday, October 24, 2018 / Notices
experience, and medical condition of
each applicant were stated and
discussed in detail in the August 15,
2018, Federal Register notice (83 FR
40642) and will not be repeated in this
notice.
These 39 applicants have had ITDM
over a range of 1 to 59 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (two or more) severe
hypoglycemic episodes in the past five
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes related
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
amozie on DSK3GDR082PROD with NOTICES1
V. Conditions and Requirements
The terms and conditions of the
exemption are provided to the
applicants in the exemption document
and includes the following: (1) Each
driver must submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) each driver must
report within two business days of
occurrence, all episodes of severe
hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) each driver must
provide a copy of the ophthalmologist’s
or optometrist’s report to the Medical
Examiner at the time of the annual
medical examination; and (4) each
driver must provide a copy of the
annual medical certification to the
employer for retention in the driver’s
qualification file, or keeping a copy in
his/her driver’s qualification file if he/
she is self-employed. The driver must
also have a copy of the exemption when
driving, for presentation to a duly
authorized Federal, State, or local
enforcement official.
VerDate Sep<11>2014
17:43 Oct 23, 2018
Jkt 247001
VI. Preemption
During the period the exemption is in
effect, no State shall enforce any law or
regulation that conflicts with this
exemption with respect to a person
operating under the exemption.
VII. Conclusion
Frm 00135
Fmt 4703
[FR Doc. 2018–23230 Filed 10–23–18; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Based upon its evaluation of the 39
exemption applications, FMCSA
exempts the following drivers from the
diabetes requirement in 49 CFR
391.41(b)(10), subject to the
requirements cited above:
Jeffrey L. Barton (KS)
Michael J. Beattie (TN)
Timothy W. Beeny (KY)
Joseph A. Bradley (IN)
Harold B. Bryan (ID)
Javis B. Cruz (NM)
Matthew A. Cunningham (NY)
Victor J. Da-Chao (MD)
Timothy S. Danley (TX)
Richard G. Dattler, Jr. (OR)
Ellen M. Diggs (KS)
Marven J. Finken (MN)
Randie S. Fisher, Jr. (MO)
Jason J. Fleisch (PA)
Ryan M. Galusha (NY)
Raymond M. Hamlin (ME)
Steven L. Hare, Jr. (NC)
Joshua R. Hedges (MO)
Vicky L. Hill (WA)
Charles O. Hudson (TN)
James A. Keebaugh (PA)
Rein R. Kori (TN)
Thomas C. McGee (SC)
Anton Means (IL)
Andrew P. Metze (SC)
Christopher J. Misner (MI)
Mohamed S. Mohamed (MA)
Eugene G. Mueller (WI)
Reginald J. Pokorny (NE)
Vernon C. Read (CA)
John W. Rosenthal (ID)
Steven A. Santamaria (IL)
Ricky J. Sawyer (AL)
Justin G. Simpson (OH)
Jacob H. Turner (AR)
Chad E. Vanscoy (OH)
Phillip M. Woods (MI)
Robert W. Youdath (OH)
Brian D. Zoll (OH)
In accordance with 49 U.S.C. 31136(e)
and 31315, each exemption will be valid
for two years from the effective date
unless revoked earlier by FMCSA. The
exemption will be revoked if the
following occurs: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained prior to being granted;
or (3) continuation of the exemption
would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and
31315.
PO 00000
Issued on: October 15, 2018.
Larry W. Minor,
Associate Administrator for Policy.
Sfmt 4703
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2018–0032]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 54 individuals from
the prohibition in the Federal Motor
Carrier Safety Regulations (FMCSRs)
against persons with insulin-treated
diabetes mellitus (ITDM) from operating
a commercial motor vehicle (CMV) in
interstate commerce. The exemptions
enable these individuals with ITDM to
operate CMVs in interstate commerce.
DATES: The exemptions were applicable
on August 17, 2018. The exemptions
expire on August 17, 2020.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Programs
Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001. Office
hours are from 8:30 a.m. to 5 p.m., ET,
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing or submitting
material to the docket, contact Docket
Services, telephone (202) 366–9826.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Public Participation
A. Viewing Documents and Comments
To view comments, as well as any
documents mentioned in this notice as
being available in the docket, go to
https://www.regulations.gov. Insert the
docket number, FMCSA–2018–0032, in
the keyword box, and click ‘‘Search.’’
Next, click the ‘‘Open Docket Folder’’
button and choose the document to
review. If you do not have access to the
internet, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
on the Ground Floor of the DOT West
Building, 1200 New Jersey Avenue SE,
Washington, DC 20590, between 9 a.m.
and 5 p.m., ET, Monday through Friday,
except Federal holidays.
E:\FR\FM\24OCN1.SGM
24OCN1
Agencies
[Federal Register Volume 83, Number 206 (Wednesday, October 24, 2018)]
[Notices]
[Pages 53737-53738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23230]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2018-0202]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt 39 individuals from the
prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs)
against persons with insulin-treated diabetes mellitus (ITDM) from
operating a commercial motor vehicle (CMV) in interstate commerce. The
exemptions enable these individuals with ITDM to operate CMVs in
interstate commerce.
DATES: The exemptions were applicable on September 15, 2018. The
exemptions expire on September 15, 2020.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, (202) 366-4001, [email protected], FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Services, telephone (202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
A. Viewing Documents and Comments
To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to https://www.regulations.gov.
Insert the docket number, FMCSA-2018-0202, in the keyword box, and
click ``Search.'' Next, click the ``Open Docket Folder'' button and
choose the document to review. If you do not have access to the
internet, you may view the docket online by visiting the Docket
Management Facility in Room W12-140 on the Ground Floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9
a.m. and 5 p.m., ET., Monday through Friday, except Federal holidays.
B. Privacy Act
In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.
II. Background
On August 15, 2018, FMCSA published a notice announcing receipt of
applications from 39 individuals requesting an exemption from diabetes
requirement in 49 CFR 391.41(b)(3) and requested comments from the
public (83 FR 40642). The public comment period ended on September 14,
2018, and no comments were received.
FMCSA has evaluated the eligibility of these applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
The physical qualification standard for drivers regarding diabetes
found in 49 CFR 391.41(b)(3) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control.
III. Discussion of Comments
FMCSA received no comments in this proceeding.
IV. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
for up to five years from the diabetes standard in 49 CFR 391.41(b)(3)
if the exemption is likely to achieve an equivalent or greater level of
safety than would be achieved without the exemption. The exemption
allows the applicants to operate CMVs in interstate commerce. FMCSA
grants exemptions from the FMCSRs for a two-year period to align with
the maximum duration of a driver's medical certification.
The Agency's decision regarding these exemption applications is
based on the program eligibility criteria and an individualized
assessment of information submitted by each applicant. The
qualifications,
[[Page 53738]]
experience, and medical condition of each applicant were stated and
discussed in detail in the August 15, 2018, Federal Register notice (83
FR 40642) and will not be repeated in this notice.
These 39 applicants have had ITDM over a range of 1 to 59 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (two
or more) severe hypoglycemic episodes in the past five years. In each
case, an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
V. Conditions and Requirements
The terms and conditions of the exemption are provided to the
applicants in the exemption document and includes the following: (1)
Each driver must submit a quarterly monitoring checklist completed by
the treating endocrinologist as well as an annual checklist with a
comprehensive medical evaluation; (2) each driver must report within
two business days of occurrence, all episodes of severe hypoglycemia,
significant complications, or inability to manage diabetes; also, any
involvement in an accident or any other adverse event in a CMV or
personal vehicle, whether or not it is related to an episode of
hypoglycemia; (3) each driver must provide a copy of the
ophthalmologist's or optometrist's report to the Medical Examiner at
the time of the annual medical examination; and (4) each driver must
provide a copy of the annual medical certification to the employer for
retention in the driver's qualification file, or keeping a copy in his/
her driver's qualification file if he/she is self-employed. The driver
must also have a copy of the exemption when driving, for presentation
to a duly authorized Federal, State, or local enforcement official.
VI. Preemption
During the period the exemption is in effect, no State shall
enforce any law or regulation that conflicts with this exemption with
respect to a person operating under the exemption.
VII. Conclusion
Based upon its evaluation of the 39 exemption applications, FMCSA
exempts the following drivers from the diabetes requirement in 49 CFR
391.41(b)(10), subject to the requirements cited above:
Jeffrey L. Barton (KS)
Michael J. Beattie (TN)
Timothy W. Beeny (KY)
Joseph A. Bradley (IN)
Harold B. Bryan (ID)
Javis B. Cruz (NM)
Matthew A. Cunningham (NY)
Victor J. Da-Chao (MD)
Timothy S. Danley (TX)
Richard G. Dattler, Jr. (OR)
Ellen M. Diggs (KS)
Marven J. Finken (MN)
Randie S. Fisher, Jr. (MO)
Jason J. Fleisch (PA)
Ryan M. Galusha (NY)
Raymond M. Hamlin (ME)
Steven L. Hare, Jr. (NC)
Joshua R. Hedges (MO)
Vicky L. Hill (WA)
Charles O. Hudson (TN)
James A. Keebaugh (PA)
Rein R. Kori (TN)
Thomas C. McGee (SC)
Anton Means (IL)
Andrew P. Metze (SC)
Christopher J. Misner (MI)
Mohamed S. Mohamed (MA)
Eugene G. Mueller (WI)
Reginald J. Pokorny (NE)
Vernon C. Read (CA)
John W. Rosenthal (ID)
Steven A. Santamaria (IL)
Ricky J. Sawyer (AL)
Justin G. Simpson (OH)
Jacob H. Turner (AR)
Chad E. Vanscoy (OH)
Phillip M. Woods (MI)
Robert W. Youdath (OH)
Brian D. Zoll (OH)
In accordance with 49 U.S.C. 31136(e) and 31315, each exemption
will be valid for two years from the effective date unless revoked
earlier by FMCSA. The exemption will be revoked if the following
occurs: (1) The person fails to comply with the terms and conditions of
the exemption; (2) the exemption has resulted in a lower level of
safety than was maintained prior to being granted; or (3) continuation
of the exemption would not be consistent with the goals and objectives
of 49 U.S.C. 31136(e) and 31315.
Issued on: October 15, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-23230 Filed 10-23-18; 8:45 am]
BILLING CODE 4910-EX-P